VX-445 Combination Therapy

elexacaftor/tezacaftor/ivacaftor · Vertex Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VX-445 Combination Therapy, covering 2024-05-08 to 2024-05-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy [Phase 3]